Daniele Dionisio - New to IQsensato’s Guest Papers section is a short paper entitled Cutting edge fixed-dose brand HIV drug combinations to speed up enforcement of UNITAID patent pool plan contributed by myself (Member, European Parliament Working Group on Innovation, Access to Medicines and Poverty-Related Diseases).
Archive for the ‘AIDS’ Category
Cutting edge fixed-dose brand HIV drug combinations to speed up enforcement of UNITAID patent pool plan
Monday, June 7th, 2010Three books on IP launched in Brazil
Wednesday, February 24th, 2010Pedro Paranagua – Brazil’s Fundação Getulio Vargas (FGV), a higher education institution comprised of four Schools (Economic, Business, Law, and Social Science), placed amongst the world’s top-5 “policy-maker think-tank” according to the US magazine Foreign Policy has launched three new books (in Brazilian Portuguese) on intellectual property -related fields.
Who Owns the HIV Genome Knowledge and Why the Deafening Silence?
Monday, September 7th, 2009Hope you didn’t blink the other week or you may have missed the fact that they have mapped the HIV genome. It was in the journal Nature, on the BBC News and on Medical News Today website, among others. It’s great news as it opens up all sorts of health benefits. My worry is that it may not be great news for everyone, and the point is that the public does not know who owns the information and, therefore, does not know who can benefit or at what cost.
HIV/AIDS Treatment – A Call to Join the Bomb Squad to Defuse a Timebomb
Friday, July 24th, 2009By 2030 an estimated 50 million people will need HIV/AIDS treatment compared to only 9 million who need the treatment today. This is the projection of the UK All-Party Parliamentary Group on AIDS (APPG) contained in – The Treatment Timebomb – a report released on 15th July 2009 in London. The report contains the findings of an inquiry of the APPG into the long-term access to HIV medicines in the developing world.
